Inventor
Meibi DAI
Inventor
CN
Overview
Patents· 8 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations32%
C07DHeterocyclic compounds32%
A61KPreparations for medical, dental or toiletry purposes24%
C07BGeneral methods of organic chemistry8%
C07CAcyclic or carbocyclic compounds4%
PatentTitleYear
12,509,440Fluorovinylbenzamide compound as PD-L1 immunomodulator202512,378,241Pyridine derivative as FGFR and VEGFR dual inhibitors202512,312,347Azaindole derivative and use thereof as FGFR and C-Met inhibitor202512,297,197Pyrazolopyridine compound as RET inhibitor and application thereof202512,152,013Vinylpyridine carboxamide compound as PD-L1 immunomodulator202411,919,898Crystal form of azaindole derivative and use thereof202411,440,903Salt form and crystal form of compound as FGFR4 inhibitor and preparation method thereof202211,161,817Quinoline derivative and use thereof as tyrosine kinase inhibitor2021Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2021Patents assigned to CHONGQING PHARMACEUTICAL INDUSTRIAL RES INSTITUTE CO LTD (1)· patent assignee history
2021–2025Based in CN· patent location history
2022Patents assigned to GUANGDONG XIANQIANG PHARMACEUTICAL CO LTD (1)· patent assignee history
2024–2025Patents assigned to NOVAONCO JS THERAPEUTICS CO LTD (2)· patent assignee history
2024–2025Patents assigned to WUXI LIFE FOUNTAIN BIOTECH CO LTD (2)· patent assignee history
2025Patents assigned to CGENETECH SUZHOU CHINA CO LTD (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| NOVAONCO JS THERAPEUTICS CO LTD | 2 | 2024–2025 |
| WUXI LIFE FOUNTAIN BIOTECH CO LTD | 2 | 2024–2025 |
| CGENETECH SUZHOU CHINA CO LTD | 1 | 2025 |
| CHONGQING PHARMACEUTICAL INDUSTRIAL RES INSTITUTE CO LTD | 1 | 2021 |
| GUANGDONG XIANQIANG PHARMACEUTICAL CO LTD | 1 | 2022 |
Locations
| Location | Patents | Span |
|---|---|---|
| CN | 8 | 2021–2025 |